Lupin's Pithampur facility successfully concludes UK MHRA inspection

Lupin announced the successful completion of the inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK) at its three manufacturing units in Pithampur (India).

The inspection for the three units at Pithampur closed with no critical observation and one major observation.

Powered by Capital Market - Live News